Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 149

Similar articles for PubMed (Select 9808130)

1.

Villoglandular adenocarcinoma of the endometrium: a clinicopathologic study of 61 cases: a gynecologic oncology group study.

Zaino RJ, Kurman RJ, Brunetto VL, Morrow CP, Bentley RC, Cappellari JO, Bitterman P.

Am J Surg Pathol. 1998 Nov;22(11):1379-85.

PMID:
9808130
2.

Is there a difference in outcome between stage I-II endometrial cancer of papillary serous/clear cell and endometrioid FIGO Grade 3 cancer?

Alektiar KM, McKee A, Lin O, Venkatraman E, Zelefsky MJ, McKee B, Hoskins WJ, Barakat RR.

Int J Radiat Oncol Biol Phys. 2002 Sep 1;54(1):79-85.

PMID:
12182977
3.

The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.

Cirisano FD Jr, Robboy SJ, Dodge RK, Bentley RC, Krigman HR, Synan IS, Soper JT, Clarke-Pearson DL.

Gynecol Oncol. 2000 Apr;77(1):55-65.

PMID:
10739691
4.

Uterine papillary serous carcinoma (pure and mixed type) compared with moderately and poorly differentiated endometrioid carcinoma. A clinicopathologic study.

Halperin R, Zehavi S, Langer R, Hadas E, Bukovsky I, Schneider D.

Eur J Gynaecol Oncol. 2002;23(4):300-4.

PMID:
12214728
5.

Cell proliferation-associated proteins in endometrial carcinomas, including papillary serous and endometrioid subtypes.

Kallakury BV, Ambros RA, Hayner-Buchan AM, Sheehan CE, Malfetano JH, Ross JS.

Int J Gynecol Pathol. 1998 Oct;17(4):320-6.

PMID:
9785132
6.

Pathological findings in early-stage endometrial cancer.

Zehavi S, Schneider D, Bukovsky I, Halperin R.

Eur J Gynaecol Oncol. 2003;24(1):18-20.

PMID:
12691310
7.

Papillary serous and clear cell type lead to poor prognosis of endometrial carcinoma in black women.

Matthews RP, Hutchinson-Colas J, Maiman M, Fruchter RG, Gates EJ, Gibbon D, Remy JC, Sedlis A.

Gynecol Oncol. 1997 May;65(2):206-12.

PMID:
9159326
8.

Epidemiologic and surgicopathologic findings of papillary serous and clear cell endometrial cancers when compared to endometrioid carcinoma.

Cirisano FD Jr, Robboy SJ, Dodge RK, Bentley RC, Krigman HR, Synan IS, Soper JT, Clarke-Pearson DL.

Gynecol Oncol. 1999 Sep;74(3):385-94.

PMID:
10479498
10.

Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.

Benedetti Panici P, Basile S, Maneschi F, Alberto Lissoni A, Signorelli M, Scambia G, Angioli R, Tateo S, Mangili G, Katsaros D, Garozzo G, Campagnutta E, Donadello N, Greggi S, Melpignano M, Raspagliesi F, Ragni N, Cormio G, Grassi R, Franchi M, Giannarelli D, Fossati R, Torri V, Amoroso M, Crocè C, Mangioni C.

J Natl Cancer Inst. 2008 Dec 3;100(23):1707-16. doi: 10.1093/jnci/djn397. Epub 2008 Nov 25.

11.

E-cadherin expression in endometrioid, papillary serous, and clear cell carcinoma of the endometrium.

Holcomb K, Delatorre R, Pedemonte B, McLeod C, Anderson L, Chambers J.

Obstet Gynecol. 2002 Dec;100(6):1290-5.

PMID:
12468176
12.

Significance of papillary (villoglandular) differentiation in endometrioid carcinoma of the uterus.

Ambros RA, Ballouk F, Malfetano JH, Ross JS.

Am J Surg Pathol. 1994 Jun;18(6):569-75.

PMID:
8179072
14.

Endometrioid endometrial adenocarcinoma with psammoma bodies.

Parkash V, Carcangiu ML.

Am J Surg Pathol. 1997 Apr;21(4):399-406.

PMID:
9130986
15.

Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion.

Orezzoli JP, Sioletic S, Olawaiye A, Oliva E, del Carmen MG.

Gynecol Oncol. 2009 Jun;113(3):316-23. doi: 10.1016/j.ygyno.2009.03.007. Epub 2009 Apr 5.

PMID:
19345400
17.

Ten-year outcome including patterns of failure and toxicity for adjuvant whole abdominopelvic irradiation in high-risk and poor histologic feature patients with endometrial carcinoma.

Stewart KD, Martinez AA, Weiner S, Podratz K, Stromberg JS, Schray M, Mitchell C, Sherman A, Chen P, Brabbins DA.

Int J Radiat Oncol Biol Phys. 2002 Oct 1;54(2):527-35.

PMID:
12243832
18.
19.

Clinicopathologic features and genetic alterations in endometrioid carcinoma of the uterus with villoglandular differentiation.

Esteller M, Garcia A, Martinez-Palones JM, Xercavins J, Reventos J.

Am J Clin Pathol. 1999 Mar;111(3):336-42.

PMID:
10078108
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk